Arbor Pharmaceuticals is led by a team of skilled pharmaceutical veterans, many of whom have experience as healthcare practitioners. Our people fully understand the pharmaceutical development process and the value that our products can bring to the lives of our patients. The Arbor team is now 600 strong and has full knowledge and capabilities in pharmaceutical research and development, manufacturing, quality control and market commercialization. We work with over a dozen partners throughout the world for the licensing, manufacturing or development of our marketed and late stage pipeline products.
Arbor Pharmaceuticals has established the goal of becoming the largest privately owned U.S. pharmaceutical company. We are currently working with many of the local universities and discovery centers to identify and keep those innovations in the Atlanta economy through partnerships with Arbor. Our focus is on identifying opportunities that can be brought to the market quickly, with minimal risk and that offer improved outcomes for our patients.
The Arbor Board is comprised of several individuals that have founded, created and led pharmaceutical companies ranging in value from several hundred million to over six billion dollars in market value. Arbor has the management team, products and development projects needed to create the foundation for a strong, sustainable pharmaceutical company that will continually find ways to improve the lives of our patients.